Age of the company
3 yearsCapital in CHF
638'062Active brands
0Reports for Cimeio Therapeutics AG
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out moreEconomic information
Comprehensive information about the economic situation of a company. Find out morePayment collection information
Overview of current and past debt enforcement proceedings. Find out moreCompany dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data. Retrieve company dossierAbout Cimeio Therapeutics AG
- Cimeio Therapeutics AG with its legal headquarters in Basel is active. Cimeio Therapeutics AG operates in the sector «Production of pharmaceutical substances».
- The management has 9 active persons registered.
- Under «Notifications» you can see all modifications to the commercial register entry. The most recent modification was on 27.01.2023.
- The Enterprise Identification Number of the company Cimeio Therapeutics AG is the following: CHE-465.367.689.
- The address is identical with 30 other active companies. These include: AlpENa Biosciences AG, Basel Tourismus, Boutique Danoise AG.
Management (9)
newest board members
Dr. Luca Santarelli,
Dr. Markus Michael Enzelberger,
Alexander Mayweg,
Josef Lukas Jeker
newest authorized signatories
Dr. Luca Santarelli,
Daniel Stark,
Tristan Imbert,
Dr. Markus Michael Enzelberger,
Thomas Henry Fuchs
Commercial register information
Entry in the commercial register
29.07.2020
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Basel
Commercial Registry Office
BS
Commercial register number
CH-280.3.024.812-1
UID/VAT
CHE-465.367.689
Sector
Production of pharmaceutical substances
Purpose (Original language) Customise the company purpose with just a few clicks.
Die Gesellschaft bezweckt die Entwicklung, die Produktion und den Vertrieb von pharmazeutischen und immunopharmazeutischen Produkten sowie die Erbringung damit im Zusammenhang stehenden Dienstleistungen. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland beteiligen, solche gründen, übernehmen und mit ihnen fusionieren. Sie kann Liegenschaften und Immaterialgüterrechte im In- und Ausland erwerben, belasten und veräussern sowie durch Beschluss des Verwaltungsrates Zweigniederlassungen und Agenturen im In- oder Ausland errichten.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| KPMG AG | Basel | 27.01.2023 | ||
Former auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young AG | Basel | 03.08.2020 | 26.01.2023 | |
Other company names
Past and translated company names
- Cimeio Therapeutics Ltd
- Cimeio Therapeutics SA
Ownership structure
Holdings
Newest SOGC notifications: Cimeio Therapeutics AG
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1005663388, Commercial Registry Office Basel-Stadt, (270)
Cimeio Therapeutics AG, in Basel, CHE-465.367.689, Aktiengesellschaft (SHAB Nr. 230 vom 25.11.2022, Publ. 1005612988).
Ausgeschiedene Personen und erloschene Unterschriften:
Ernst & Young AG (CHE-105.932.265), in Basel, Revisionsstelle.
Eingetragene Personen neu oder mutierend:
KPMG AG (CHE-154.017.048), in Basel, Revisionsstelle.
Publication number: HR02-1005612988, Commercial Registry Office Basel-Stadt, (270)
Cimeio Therapeutics AG, in Basel, CHE-465.367.689, Aktiengesellschaft (SHAB Nr. 185 vom 23.09.2022, Publ. 1005567979).
Statutenänderung:
21.11.2022.
Aktienkapital neu:
CHF 1'097'993.60 [bisher: CHF 1'063'423.78].
Liberierung Aktienkapital neu:
CHF 1'097'993.60 [bisher: CHF 1'063'423.78].
Aktien neu:
9'899'680 Namenaktien zu CHF 0.02 und 45'000'000 Namenaktien zu CHF 0.02 (Vorzugsaktien) [bisher: 45'000'000 Namenaktien zu CHF 0.02 (Vorzugsaktien) und 8'171'189 Namenaktien zu CHF 0.02]. Kapitalerhöhung aus genehmigtem Aktienkapital.
Publication number: HR02-1005567979, Commercial Registry Office Basel-Stadt, (270)
Cimeio Therapeutics AG, in Basel, CHE-465.367.689, Aktiengesellschaft (SHAB Nr. 107 vom 03.06.2022, Publ. 1005487991).
Eingetragene Personen neu oder mutierend:
Santarelli, Luca, italienischer Staatsangehöriger, in Basel, Mitglied des Verwaltungsrates, mit Kollektivunterschrift zu zweien.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.